AKT1 and psychotic disorder: In contrast to COMT, novel evidence suggests that AKT1 may not only act as a modifier, but may also be a predictive biomarker for people who are biologically susceptible to psychosis following even lower levels of exposure to cannabis. It is unclear whether these genes play a causal role in the absence of marijuana.